Our cell culture data conflicts with a series of mouse studies reporting that treatment with OSM improved insulin sensitivity, while the absence of OSM signalling in adipocytes gave rise to insulin resistance [5,15–17]. The gene discussed is INS; the disease is Insulin resistance.